Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) announced that it will hold a board of directors meeting on August 12, 2024 (Monday) to consider and approve (including) the unaudited interim performance of the company and its subsidiaries for the six months ended June 30, 2024 and the declaration of interim dividends (if any).
复旦张江(01349.HK)8月12日举行董事会会议审议及通过中期业绩
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) held a board of directors meeting on August 12 to review and approve its interim performance.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.